Quest Diagnostics Incorporated DGX
- Market cap
- $26.2B
- P/E
- 24.8×
Follow DGX
Quest Diagnostics Incorporated (DGX) EV/Sales
As of 25 September 2026, Quest Diagnostics Incorporated (DGX) trades at a EV/Sales of 2.7×. Over the past ten years it has ranged from 1.6× (September 2015) to 2.8× (September 2026); the current reading is higher than 99% of that period. That is below the Diagnostics & Research industry median of 5.7× and below the Healthcare sector median of 3.6×.
EV/Sales, daily
Annual
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 2.2× | (2.16%) |
| FY2024 | 2.3× | 6.09% |
| FY2023 | 2.1× | (2.69%) |
| FY2022 | 2.2× | (4.20%) |
| FY2021 | 2.3× | 15.08% |
| FY2020 | 2.0× | (13.84%) |
| FY2019 | 2.3× | 15.60% |
| FY2018 | 2.0× | (13.79%) |
| FY2017 | 2.3× | 2.71% |
| FY2016 | 2.3× | 23.16% |
Quarterly
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 2.5× | 3.82% |
| Mar 2026 | 2.4× | 7.06% |
| Dec 2025 | 2.2× | (9.35%) |
| Sep 2025 | 2.5× | 1.22% |
| 42 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| LH Labcorp Holdings Inc. compare | 2.2× |
| DGX Quest Diagnostics Incorporated | 2.7× |
| MEDP Medpace Holdings, Inc. compare | 6.1× |
| RVTY Revvity Inc. compare | 6.5× |
| MTD Mettler-Toledo International, Inc. compare | 7.9× |
| IDXX IDEXX Laboratories, Inc. compare | 9.1× |
| ILMN Illumina, Inc. compare | 9.3× |
| WAT Waters Corporation compare | 10.1× |
| GH Guardant Health, Inc. compare | 20.3× |
| Diagnostics & Research industry median | 5.7× |
| Healthcare sector median | 3.6× |
| Market median | 2.2× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)
More on DGX
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement